Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply. [electronic resource]

By: Contributor(s): Producer: 20171220Description: 1372 p. digitalISSN:
  • 1365-2036
Subject(s): Online resources: In: Alimentary pharmacology & therapeutics vol. 45
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Editorial; Comment

There are no comments on this title.

to post a comment.